|
|
Volumn 7, Issue 6, 1997, Pages 571-588
|
|
Protein tyrosine kinase inhibitors in cancer treatment
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 (3 BROMOANILINO) 6 (METHYLAMINO)PYRIDO[3,4 D]PYRIMIDINE;
4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE;
4,5 DIANILINOPHTHALIMIDE;
ANILINE DERIVATIVE;
ANTINEOPLASTIC AGENT;
CGP 59326;
CGP 60261;
CGP 62706;
CP 292597;
CYTOTOXIC AGENT;
ENZYME INHIBITOR;
ERLOTINIB;
GEFITINIB;
IMATINIB;
LEFLUNOMIDE;
N [4 METHYL 3 [4 (3 PYRIDINYL) 2 PYRIMIDINYLAMINO]PHENYL]BENZAMIDE;
PD 157655;
PD 158254;
PD 161176;
PD 166285;
PHTHALIMIDE DERIVATIVE;
PROTEIN TYROSINE KINASE INHIBITOR;
PYRAZOLOPYRIMIDINE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
PYRROLOPYRIMIDINE DERIVATIVE;
QUINAZOLINE DERIVATIVE;
SU 1433;
SU 1498;
TYRPHOSTIN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
CANCER CHEMOTHERAPY;
CANCER RESEARCH;
DRUG RESEARCH;
DRUG SCREENING;
HUMAN;
MALIGNANT NEOPLASTIC DISEASE;
NONHUMAN;
REVIEW;
|
|
EID: 0030992914
PISSN: 13543776
EISSN: None
Source Type: Journal
DOI: 10.1517/13543776.7.6.571 Document Type: Review |
|
Times cited : (78)
|
|
References (64)
|
